Has Anuja Vyas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $35,188 in general payments to Anuja Vyas, MD across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anuja Vyas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anuja Vyas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anuja Vyas, MD

Pulmonary Disease · la Jolla, CANPI 1316171283

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.9%), education and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 97.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $16,256, more than ten times the $134 reported in 2021. Among pulmonary disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,188in general payments, 2019–2025

Across 43 payments — averaging $818.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$34K
Pulmonx Corporation$204
Edwards Lifesciences$197
Pinnacle Biologics, Inc$196
Olympus America Inc.$133
Novo Nordisk$100
plus $34 from 2 others

What the payments were for

Speaking & faculty fees$16,50047%
Travel & lodging$8312%
Food & beverage$3,2139%
Education$14,64442%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	34	$34,324
Pulmonx Corporation	2	$204
Edwards Lifesciences	1	$197
Pinnacle Biologics, Inc	2	$196
Olympus America Inc.	1	$133
Novo Nordisk	1	$100
United Therapeutics Corporation	1	$19
Cook Medical LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,188 in reported general payments places this provider in the 90th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California →

Medicare billing

Part B allowed, 2024

$65,252

Medicare patients

196

Services billed

566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ZemairaAlpha-1-Proteinase Inhibitor	13	$166,066
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	134	$113,830
Dupixent PenDupilumab	11	$42,186
Advair HfaFluticasone Propion/Salmeterol	17	$6,713
SymbicortBudesonide/Formoterol Fumarate	26	$6,320
Spiriva RespimatTiotropium Bromide	11	$5,498
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	11	$5,059
Arnuity ElliptaFluticasone Furoate	11	$3,172
Montelukast Sodium	41	$928
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	11	$628
Albuterol Sulfate HfaAlbuterol Sulfate	20	$539
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	20	$531
Azelastine Hcl	16	$531
Ipratropium Bromide	19	$507
Prednisone	49	$264

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in la Jolla

Timothy Fernandesla Jolla$129K
Samuel LouieSacramento$2.8M
Shyamsunder SubramanianTracy$1.5M
Toby MaherLos Angeles$1.3M
Rajkumar DasguptaPasadena$930K
Hoang leFountain Valley$814K
Kevin FussellEncinitas$788K
Revati ShreeniwasStanford$726K
David PhamWestminster$571K
Vijay BalasubramanianFresno$529K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →